Jyoti Srivastava, Ph.D.
Dr. Jyoti Srivastava, Ph.D. is a Senior Research Scientist at Moffitt Cancer Center in Tampa, Florida, where she leads innovative research focused on improving therapies for aggressive and treatment-resistant cancers. Her current work explores how targeting specific molecular pathways can enhance the effectiveness of cancer treatments and promote immune-mediated tumor cell elimination. With more than two decades of experience in cancer biology and molecular signaling, Dr. Srivastava specializes in translating laboratory research into potential therapeutic strategies. Her expertise lies in immuno-oncology, drug resistance, and tumor biology, contributing to the development of more targeted and durable cancer treatments. Dr. Srivastava earned her Ph.D. in immunology and tumor biology and has held various research and leadership roles in both academic and biotechnology settings. She is widely respected for her contributions to the field and remains committed to advancing cancer science to improve patient outcomes.
• National Institute of Immunology - Ph.D
What advice would you give to young women entering your industry?
My advice to young women entering this industry is to follow your dreams—regardless of where you come from. Your background does not define your potential. With passion, perseverance, and a clear sense of purpose, you can create a meaningful path in education and make a lasting impact on the lives of others. Believe in yourself and don’t be afraid to take the first step.